首頁 > 市場調查報告書 > 食物/飲料

食品添加劑機能性食品

市場調查報告書

商品編碼

1550774

人乳寡糖市場：按應用、按類型、按地區

Human Milk Oligosaccharides Market, By Application, By Type, By Geography

出版日期: 2024年07月30日 | 出版商:

Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

人乳寡糖(HMO) 市場預計 2024 年為 2.986 億美元，預計到 2031 年將達到 7.705 億美元，2024 年至 2031 年複合年成長率為 14.5%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	2.986 億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測 2024-2031 年複合年成長率：	14.50%	2031年價值預測	7.705 億美元

圖.2024年按地區分類的人乳寡糖市場佔有率（%）

人乳寡糖(HMO) 是母乳中發現的複合糖，可支持嬰兒腸道有益細菌的生長，並提供對致病菌的保護。作為母乳中繼乳糖和脂肪之後第三豐富的固態成分，HMO 模仿嬰兒腸道黏膜內層的成分，可防止病原體在腸壁上附著和定殖。研究和開發表明，HMO 可促進嬰兒大腦發育並刺激免疫細胞發育。 HMO 已被證明具有與母乳相似的益生元和營養特性，因此正在被納入嬰兒奶粉中，為奶瓶餵食的嬰兒提供健康益處。

市場動態：

人們越來越認知到 HMO 在嬰兒營養和市場開發中的重要性，推動了全球人乳寡糖市場的發展。由於許多母親面臨母乳哺育困難，對 HMO 強化嬰兒奶粉的需求顯著增加。主要市場參與者已開發出透過發酵各種乳製品和蔬菜原料生產 HMO 的技術能力。然而，生產過程的高成本對市場成長構成挑戰。正在進行的專注於降低生產成本的研究可能會為 HMO 在嬰兒營養之外的臨床營養、個人護理以及補充食品和飲料等領域的更廣泛應用帶來機會。

本研究的主要特點

本報告詳細分析了全球人乳寡糖市場，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還闡明了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它包括基於公司亮點、產品系列、主要亮點、績效和策略等參數的全球人乳寡糖市場主要企業的概況。
該報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球人乳寡糖市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球人乳寡糖市場的各種策略矩陣來促進他們的決策。

市場佔有率分析
公司簡介
- ZuChem Inc.
- Merck &Co. Inc.
- Chr. Hansen Holding AS
- Royal FrieslandCampina NV
- BASF
- IFF（DuPont Nutrition &Health）
- Gnubiotics
- Inbiose NV
- Carbosynth Holdings Limited
- Royal DSM NV
- Kyowa Hakko Europe GmbH
- Elicityl SA
- FrieslandCampina Ingredients
- Glycom A/S
- Dextra Laboratories Limited
- Rajvi Enterprise

第9章分析師建議

命運之輪
分析師觀點
一致的機會圖

第10章

參考
調查方法

簡介目錄

Product Code: CMI5064

The human milk oligosaccharides market is estimated to be valued at USD 298.6 Mn in 2024 and is expected to reach USD 770.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 298.6 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	14.50%	2031 Value Projection:	US$ 770.5 Mn

Figure. Human Milk Oligosaccharides Market Share (%), By Region 2024

Human Milk Oligosaccharides Market - IMG1

Human milk oligosaccharides (HMOs) are complex sugars found in breastmilk that support the growth of beneficial gut bacteria in infants and provide protection against pathogenic bacteria. As the third most abundant solid component in breastmilk after lactose and fat, HMOs mimic components of the mucosal layer in the infant gut and prevent pathogens from attaching to and colonizing the intestinal wall. Research has shown that HMOs can promote brain development and stimulate immune cell development in infants. Due to their demonstrated prebiotic and nutritional properties similar to human breastmilk, HMOs are being incorporated into infant formula to deliver health benefits to bottle-fed babies.

Market Dynamics:

The global human milk oligosaccharides market is driven by growing awareness about the importance of HMOs in infant nutrition and development. As many mothers face difficulties in breastfeeding, the demand for HMO-fortified infant formula is increasing significantly. Major market players have developed technological capabilities to produce HMOs through the fermentation of various dairy and plant-based ingredients. However, the high costs involved in the production process pose a challenge to market growth. Ongoing research focused on reducing production costs could open up opportunities for the wider application of HMOs beyond infant nutrition in areas such as clinical nutrition, personal care, and supplemental food & beverages.

Key Features of the Study:

This report provides in-depth analysis of the global human milk oligosaccharides market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global human milk oligosaccharides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include ZuChem Inc., Merck & Co. Inc., Chr. Hansen Holding AS , Royal FrieslandCampina NV, BASF, IFF (DuPont Nutrition & Health), Gnubiotics, Inbiose NV, Carbosynth Holdings Limited, Royal DSM N.V, Kyowa Hakko Europe GmbH, Elicityl SA, FrieslandCampina Ingredients, Glycom A/S, Dextra Laboratories Limited, and Rajvi Enterprise
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global human milk oligosaccharides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human milk oligosaccharides market

Detailed Segmentation-

By Application:
- Infant Formula
- Dietary Supplements
- Functional Food and Beverage
By Type:
- 2'FL
- 3'FL
- 3'SL
- 6'SL
- LNT
- LNnT
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- ZuChem Inc.
- Merck & Co. Inc.
- Chr. Hansen Holding AS
- Royal FrieslandCampina NV
- BASF
- IFF (DuPont Nutrition & Health)
- Gnubiotics
- Inbiose NV
- Carbosynth Holdings Limited
- Royal DSM N.V
- Kyowa Hakko Europe GmbH
- Elicityl SA
- FrieslandCampina Ingredients
- Glycom A/S
- Dextra Laboratories Limited
- Rajvi Enterprise

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Type
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Mergers and Acquisitions

4. Global Human Milk Oligosaccharides Market - Impact of Coronavirus (COVID-19) Pandemic

Overview
Factors Affecting the Global Human Milk Oligosaccharides Market
Impact Analysis

5. Global Human Milk Oligosaccharides Market, By Application, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Infant Formula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
Functional Food and Beverage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends

6. Global Human Milk Oligosaccharides Market, By Type, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
2'FL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
3'FL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
3'SL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
6'SL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
LNT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
LNnT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends

7. Global Human Milk Oligosaccharides Market, By Region, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
North America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn))
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East & Africa

8. Competitive Landscape

Market Share Analysis
Company Profiles
- ZuChem Inc.
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Merck & Co. Inc.
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Chr. Hansen Holding AS
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Royal FrieslandCampina NV
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- BASF
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- IFF (DuPont Nutrition & Health)
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Gnubiotics
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Inbiose NV
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Carbosynth Holdings Limited
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Royal DSM N.V
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Kyowa Hakko Europe GmbH
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Elicityl SA
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- FrieslandCampina Ingredients
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Glycom A/S
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Dextra Laboratories Limited
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Rajvi Enterprise
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. Section

References
Research Methodology
About Us and Sales Contact
- Browse 25 market data tables* and 20 figures* on "Global Human Milk Oligosaccharides Market" - Global forecast to 2031.

02-2729-4219

+886-2-2729-4219